Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer

Over-expression of HER2 is generally considered to be a negative prognostic feature because it accompanies an increase in breast cancer mortality. However, the development of agents that specifically target HER2 has improved the management of patients with these tumours. This expert group used data...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahl, A., Singh, R., Wadhwa, J., Gupta, S., Ahmed, M., Uppal, P. N., Parikh, Purvish M., Aggarwal, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909284/
https://www.ncbi.nlm.nih.gov/pubmed/29721473
http://dx.doi.org/10.4103/sajc.sajc_111_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909284/
https://www.ncbi.nlm.nih.gov/pubmed/29721473
http://dx.doi.org/10.4103/sajc.sajc_111_18

Ejemplares similares